Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited)

v2.4.0.6
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended
Mar. 31, 2012
Mar. 31, 2011
Revenues:    
License and collaborative fees $ 1,014 $ 5,827
Contract and other 8,851 9,768
Total revenues 9,865 15,595
Operating expenses:    
Research and development 15,771 17,347
Selling, general and administrative 4,679 5,369
Restructuring 3,777 0
Total operating expenses 24,227 22,716
Loss from operations (14,362) (7,121)
Other income (expense):    
Interest expense (1,042) (532)
Other expense (664) (1,057)
Revaluation of contingent warrant liabilities (14,357) 2,390
Net loss before taxes (30,425) (6,320)
Provision for income tax expense 0 (15)
Net loss $ (30,425) $ (6,335)
Basic and diluted net loss per common stock (in dollars per share) $ (0.69) $ (0.22)
Shares used in computing basic and diluted net loss per share of common stock (in shares) 44,353 29,180